Back
Compare AU
Compare PGA1 vs. CURE
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, shares and ETFs are a popular choice. Two options in the ASX are PGA1 and CURE. In this comparison, we'll delve into these options across various dimensions to help you make an informed investment decision.
Community Stats
PGA1 | CURE | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 25 | 73 |
Median incremental investment | $3,993.50 | $660.00 |
Median investment frequency | Monthly | Monthly |
Median total investment | $7,564.06 | $1,658.80 |
Average age group | > 35 | > 35 |
Key Summary
PGA1 | CURE | |
|---|---|---|
Strategy | PGA1.AX was created on 2024-11-25 by Plato. The fund's investment portfolio concentrates primarily on total market equity. The Fund aims to outperform the Benchmark over a rolling 5-year basis | CURE.AX was created on 2018-11-08 by Global X. The fund's investment portfolio concentrates primarily on health care equity. The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the S&P Biotechnology Select Industry Index. |
Top 3 holdings | Plato Global Alpha Fund Complex ETF (100 %) | Avidity Biosciences Inc Ordinary Shares (2.52 %) Revolution Medicines Inc Ordinary Shares (2.22 %) Insmed Inc (2.15 %) |
Top 3 industries | Health Care (100.00 %) Other (10.24 %) | |
Top 3 countries | United States (97.17 %) Switzerland (1.51 %) United Kingdom of Great Britain and Northern Ireland (1.16 %) | |
Management fee | 0 % | 0.45 % |
Key Summary
PGA1 | CURE | |
|---|---|---|
Issuer | Plato | Global X |
Tracking index | MSCI World Index | S&P Biotechnology Select Industry |
Asset class | ETF | ETF |
Management fee | 0 % | 0.45 % |
Price | $13.58 | $57.20 |
Size | N/A | $36.750 million |
10Y return | N/A | N/A |
Annual dividend/ distribution yield (5Y) | 0.01 % | 5.08 % |
Market | ASX | ASX |
First listed date | 24/11/2024 | 12/11/2018 |
Purchase fee | $6.50 | $6.50 |
Community Stats
PGA1 | CURE | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 25 | 73 |
Median incremental investment | $3,993.50 | $660.00 |
Median investment frequency | Monthly | Monthly |
Median total investment | $7,564.06 | $1,658.80 |
Average age group | > 35 | > 35 |
Pros and Cons
PGA1 | CURE | |
|---|---|---|
Pros |
|
|
Cons |
|
|
PGA1 | CURE |
|---|---|
Lower exposure to US market | Higher exposure to US market |
Lower management fee | Higher management fee |
Higher price growth | Lower price growth |
Lower distribution yield | Higher distribution yield |